Analysts anticipate WAVE Life Sciences to report an earnings per share (EPS) of $-0.30.
The market awaits WAVE Life Sciences's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Earnings History Snapshot
During the last quarter, the company reported an EPS missed by $0.03, leading to a 0.74% drop in the share price on the subsequent day.
Here's a look at WAVE Life Sciences's past performance and the resulting price change:
Quarter
Q2 2025
Q1 2025
Q4 2024
Q3 2024
EPS Estimate
-0.28
-0.25
-0.22
-0.28
EPS Actual
-0.31
-0.29
0.17
-0.47
Price Change %
-1.00
1.00
-6.00
-1.00
Stock Performance
Shares of WAVE Life Sciences were trading at $7.88 as of November 06. Over the last 52-week period, shares are down 54.74%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
Analysts' Perspectives on WAVE Life Sciences
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding WAVE Life Sciences.
A total of 3 analyst ratings have been received for WAVE Life Sciences, with the consensus rating being Buy. The average one-year price ...